Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Talis Biomedical (TLIS)
NASDAQ:TLIS
Talis Biomedical (TLIS) Stock Price & Analysis
39 Followers
TLIS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.42 - $1.20
Previous Close$0.49
Volume127.39K
Average Volume (3M)115.59K
Market Cap
$29.51M
Enterprise Value-$71.45M
Total Cash (Recent Filing)$113.97M
Total Debt (Recent Filing)$14.71M
Price to Earnings (P/E)-0.1
Beta0.68
Next Earnings
Aug 08, 2023EPS Estimate
-$0.64Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.66
Shares Outstanding53,343,550
10 Day Avg. Volume247,002
30 Day Avg. Volume115,595
Standard Deviation0.16
R-Squared0.13
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-47.99
Enterprise Value/Gross Profit8.52
Enterprise Value/Ebitda0.79
Forecast
1Y Price Target
$0.35Price Target Upside-28.63% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering1
Talis Biomedical News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TLIS FAQ
What was Talis Biomedical’s price range in the past 12 months?
Talis Biomedical lowest stock price was $0.42 and its highest was $1.20 in the past 12 months.
What is Talis Biomedical’s market cap?
Currently, no data Available
When is Talis Biomedical’s upcoming earnings report date?
Talis Biomedical’s upcoming earnings report date is Aug 08, 2023 which is in 68 days.
How were Talis Biomedical’s earnings last quarter?
Talis Biomedical released its earnings results on May 11, 2023. The company reported -$0.66 earnings per share for the quarter, beating the consensus estimate of -$0.692 by $0.032.
Is Talis Biomedical overvalued?
According to Wall Street analysts Talis Biomedical’s price is currently Overvalued.
Does Talis Biomedical pay dividends?
Talis Biomedical does not currently pay dividends.
What is Talis Biomedical’s EPS estimate?
Talis Biomedical’s EPS estimate is -$0.64.
How many shares outstanding does Talis Biomedical have?
Talis Biomedical has 26,879,820 shares outstanding.
What happened to Talis Biomedical’s price movement after its last earnings report?
Talis Biomedical reported an EPS of -$0.66 in its last earnings report, beating expectations of -$0.692. Following the earnings report the stock price went down -11.538%.
Which hedge fund is a major shareholder of Talis Biomedical?
Among the largest hedge funds holding Talis Biomedical’s share is Baker Bros Advisors LP. It holds Talis Biomedical’s shares valued at 4M.
---
Talis Biomedical Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-51.96%
12-Months-Change
Fundamentals
Return on Equity
-62.51%
Trailing 12-Months
Asset Growth
-42.30%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Talis Biomedical
Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.
---
Top 5 ETFs holding TLIS
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold TLIS. The ETFs are listed according to market value of TLIS within the ETF
---
---